Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Leiomyoma 7Anemia 2

Interventions

Epoetin Alfa 27Darbepoetin alfa 13epoetin beta 3Erythropoietin 3telapristone acetate 2luspatercept 2ferric carboxymaltose 2Lenalidomide 2Ferric Oxide, Saccharated 2Cisplatin 2Blood Transfusion 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2ibrutinib 1fludarabine phosphate 1fludarabine 1ferrous sulfate 1ferric gluconate 1ferric derisomaltose 1fanasil, pyrimethamine drug combination 1Taxes 1Sugars 1Sucrose 1Solutions 1Saline Solution 1Rituximab 1Radiotherapy 1Pharmacogenomic Testing 1Paclitaxel 1Iron-Dextran Complex 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Anemia × telapristone acetate × Clear all
NCT00702702 2014-08-21

Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids

Repros Therapeutics Inc.

Phase 3 Terminated
56 enrolled 1 chart
Classical hematology

Anemia, Leiomyoma

NCT00785356 2014-08-21

Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

Repros Therapeutics Inc.

Phase 3 Terminated
8 enrolled 1 chart
Classical hematology

Anemia, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡